463-73-0

Usage

Uses

Used in Pharmaceutical Production:
Chlorocarbonic acid is used as an intermediate in the synthesis of various pharmaceuticals. Its reactivity allows for the formation of esters and other organic compounds that are essential in the development of medications.
Used in Pesticide and Herbicide Production:
Chlorocarbonic acid serves as a key intermediate in the production of pesticides and herbicides. Its ability to form esters and other organic compounds contributes to the effectiveness of these agricultural chemicals.
Used in Perfume and Flavoring Production:
Chlorocarbonic acid is utilized in the synthesis of esters, which are vital components in the creation of perfumes and flavorings. These esters provide the desired scents and tastes in various consumer products.
Used in Plasticizer Production:
Chlorocarbonic acid is employed in the production of plasticizers, which are additives used to increase the flexibility and workability of plastics. The esters derived from chlorocarbonic acid enhance the properties of plastic materials.
Note: Due to the corrosive and toxic nature of chlorocarbonic acid, it poses health and environmental risks. Therefore, it should be handled with extreme caution to ensure safety and minimize potential hazards.

InChI:InChI=1/CHClO2/c2-1(3)4/h(H,3,4)

Upstream product

• 503-38-8 trichloromethyl chloroformate 
• 75-44-5 phosgene 
• 7732-18-5 water 

Downstream Products

• 818-42-8 N,N'-ethanediyl-bis-carbamic acid diethyl ester 
• 40092-50-0 C₁₂H₁₆ClN₃O 
• 40093-15-0 C₁₃H₁₈ClN₃O 
• 40093-19-4 C₁₄H₂₀ClN₃O 
• 40092-87-3 C₁₄H₂₀ClN₃O 
• 40093-10-5 C₁₆H₂₂ClN₃O 
• 40093-08-1 C₁₇H₂₆ClN₃O 
• 40092-91-9 C₁₃H₁₈ClN₃O 
• 40092-95-3 C₁₅H₂₂ClN₃O 
• 40093-01-4 C₁₅H₂₂ClN₃O 
• 40093-06-9 C₁₅H₂₂ClN₃O 
• 42889-54-3 C₁₅H₁₇Cl₂N₃O 
• 40092-90-8 C₁₃H₁₈ClN₃O 
• 40092-48-6 C₁₁H₁₄ClN₃O 

Relevant academic research and scientific papers

PHOTOLABILE COMPOUND, OLIGOMER PROBE ARRAY AND SUBSTRATE FOR OLIGOMER PROBE ARRAY CONTAINING THE SAME, AND MANUFACTURING METHOD OF THE SAME

A photolabile compound, an oligomer probe array, and a substrate for oligomer probe array comprising the same, and a manufacturing method of the same are disclosed.

Photolabile Compound and Substrate for Oligomer Probe Array with the Same

Provided is a substrate for an oligomer probe array to which a photolabile material having an acetylene derivative is directly attached or attached via a linker.

Method of treating cancer using FPT inhibitors and antineoplastic agents

Disclosed is a method of treating cancer in a patient in need of such treatment comprising administering a therapeutically effective amount of an FPT inhibitor and therapeutically effective amounts of one or more antineoplastic agents. Methods of treating non small cell lung cancer, squamous cell cancer of the head and neck, CML, AML, non-Hodgkin's lymphoma and multiple myeloma are disclosed.

Novel farnesyl protein transferase inhibitors as antitumor agents

The present invention discloses novel tricyclic compounds represented by the formula (1.0): a prodrug thereof, or a pharmaceutically acceptable salt or solvate of the compound or of said prodrug useful for inhibiting farnesyl protein transferase. Also disclosed are pharmaceutical compositions comprising such compounds their preparation as well as methods of using them to treat proliferative diseases such as cancer.

3-Unsubstituted-3-cephem compounds

Antibacterial compounds represented by the following formula including their pharmaceutically acceptable salts and esters; process for preparing them; pharmaceutical preparation comprising them; and method for combating infections by administering them: S